BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9447983)

  • 1. A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes.
    Ribon V; Printen JA; Hoffman NG; Kay BK; Saltiel AR
    Mol Cell Biol; 1998 Feb; 18(2):872-9. PubMed ID: 9447983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes.
    Ribon V; Saltiel AR
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):839-45. PubMed ID: 9210408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes.
    Liu J; Kimura A; Baumann CA; Saltiel AR
    Mol Cell Biol; 2002 Jun; 22(11):3599-609. PubMed ID: 11997497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells.
    Mastick CC; Saltiel AR
    J Biol Chem; 1997 Aug; 272(33):20706-14. PubMed ID: 9252391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes.
    Standaert ML; Sajan MP; Miura A; Bandyopadhyay G; Farese RV
    Biochemistry; 2004 Dec; 43(49):15494-502. PubMed ID: 15581361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling.
    Ahn MY; Katsanakis KD; Bheda F; Pillay TS
    J Biol Chem; 2004 May; 279(20):21526-32. PubMed ID: 15031295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for CAP, a novel, multifunctional Src homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions.
    Ribon V; Herrera R; Kay BK; Saltiel AR
    J Biol Chem; 1998 Feb; 273(7):4073-80. PubMed ID: 9461600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
    Ribon V; Hubbell S; Herrera R; Saltiel AR
    Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of glycogen synthase by insulin in 3T3-L1 adipocytes involves c-Cbl-associating protein (CAP)-dependent and CAP-independent signaling pathways.
    Baumann CA; Brady MJ; Saltiel AR
    J Biol Chem; 2001 Mar; 276(9):6065-8. PubMed ID: 11222622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport.
    Liu J; DeYoung SM; Hwang JB; O'Leary EE; Saltiel AR
    J Biol Chem; 2003 Sep; 278(38):36754-62. PubMed ID: 12842890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates.
    Whiteman EL; Chen JJ; Birnbaum MJ
    Endocrinology; 2003 Sep; 144(9):3811-20. PubMed ID: 12933652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asb6, an adipocyte-specific ankyrin and SOCS box protein, interacts with APS to enable recruitment of elongins B and C to the insulin receptor signaling complex.
    Wilcox A; Katsanakis KD; Bheda F; Pillay TS
    J Biol Chem; 2004 Sep; 279(37):38881-8. PubMed ID: 15231829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the APS protein as a novel insulin receptor substrate.
    Moodie SA; Alleman-Sposeto J; Gustafson TA
    J Biol Chem; 1999 Apr; 274(16):11186-93. PubMed ID: 10196204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cbl PYXXM motifs activate the P85 subunit of phosphatidylinositol 3-kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes.
    Miura A; Sajan MP; Standaert ML; Bandyopadhyay G; Franklin DM; Lea-Currie R; Farese RV
    Biochemistry; 2003 Dec; 42(48):14335-41. PubMed ID: 14640702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor.
    Ahmed Z; Smith BJ; Pillay TS
    FEBS Lett; 2000 Jun; 475(1):31-4. PubMed ID: 10854852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for functional roles of Crk-II in insulin and epidermal growth factor signaling in Rat-1 fibroblasts overexpressing insulin receptors.
    Ishiki M; Sasaoka T; Ishihara H; Imamura T; Usui I; Takata Y; Kobayashi M
    Endocrinology; 1997 Nov; 138(11):4950-8. PubMed ID: 9348226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S; Burton EA; Wu SC; Anderson SM
    J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
    Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
    J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein-tyrosine kinase fer associates with signaling complexes containing insulin receptor substrate-1 and phosphatidylinositol 3-kinase.
    Iwanishi M; Czech MP; Cherniack AD
    J Biol Chem; 2000 Dec; 275(50):38995-9000. PubMed ID: 11006284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.